Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.0778538518.5855
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.846967234.9811
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.5533131304.7310
Domestic EquitiesCipla Ltd.5.5087312184.6930
Domestic EquitiesFortis Healthcare Ltd.4.7928421024.0831
Domestic EquitiesPiramal Pharma Ltd.4.45151983853.7923
Domestic EquitiesNeuland Laboratories Ltd.4.138424143.5256
Domestic EquitiesDivi's Laboratories Ltd.4.112661583.5036
Domestic EquitiesAurobindo Pharma Ltd.3.9824313013.3927
Domestic EquitiesAlkem Laboratories Ltd.3.955862123.3700
Domestic EquitiesAbbott India Ltd.3.32819682.8353
Domestic EquitiesGland Pharma Ltd.3.1212133512.6590
Domestic EquitiesArtemis Medicare Services Ltd.2.99161088322.5486
Domestic EquitiesDr Agarwal's Health Care Ltd.2.9588496842.5207
Domestic EquitiesIPCA Laboratories Ltd.2.8780183112.4518
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.7492119942.3421
Domestic EquitiesMetropolis Healthcare Ltd.2.7285114172.3245
Domestic EquitiesOnesource Specialty Pharma Ltd.2.6090120772.2227
Domestic EquitiesNavin Fluorine International Ltd.2.601847962.2165
Domestic EquitiesMankind Pharma Ltd.2.452285772.0891
Domestic EquitiesConcord Biotech Ltd.2.3868123412.0334
Domestic EquitiesGlobal Health Ltd.2.3062149521.9647
Domestic EquitiesMax Healthcare Institute Ltd.2.1949167751.8699
Domestic EquitiesSyngene International Ltd.2.0662282601.7602
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.1.953997361.6646
Domestic EquitiesVinati Organics Ltd.1.781187411.5174
Domestic EquitiesAnthem Biosciences Ltd.1.6525184951.4078
Domestic EquitiesAcutaas Chemicals Ltd.1.502197111.2797
Domestic EquitiesLinde India Ltd.1.142915590.9737
Total 97.8254 83.3396
Cash & Cash Equivalents and Net AssetsTreps2.7710 2.3607
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.5964 -0.5081
Total 2.1746 1.8526
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.